Please login to the form below

Not currently logged in
Email:
Password:

commercialisation

This page shows the latest commercialisation news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Europe reverses stance on Puma’s neratinib, Pfizer expands healthcare hubs, AbbVie and Calico boosts age-related diseases collab

Daily Brief: Europe reverses stance on Puma’s neratinib, Pfizer expands healthcare hubs, AbbVie and Calico boosts age-related diseases collab

AbbVie will have the option to manage late-stage development, and will also lead commercialisation efforts.

Latest news

More from news
Approximately 0 fully matching, plus 512 partially matching documents found.

Latest Intelligence

  • Reaching the new influencers Reaching the new influencers

    early in drug development and throughout commercialisation, gathering insights to identify clinically meaningful differentiators by engaging with the external community years ahead of launch.

  • Brexit Means Brexit Brexit Means Brexit

    CPPs, which establish the status of a pharmaceutical in the exporting country, are required by importing countries to ensure the product being registered or renewed aligns with the scope of commercialisation

  • Deal Watch January 2018

    Up to $75m per product in sales milestones. On option exercise Denali and Takeda will share 50:50 development/commercialisation costs and share profits.

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    On the other hand, Align Biopharma is tackling long-standing challenges in the commercialisation of drugs and treatments, and how HCPs engage with life science companies.

  • Flight path: the long-haul journey Flight path: the long-haul journey

    But we don’t always get it right. In the past, pharma has been guilty of developing clinical programmes simply to get a product licence - focusing purely on commercialisation and profit

More from intelligence
Approximately 1 fully matching, plus 104 partially matching documents found.

Latest appointments

  • Weekly industry appointments Weekly industry appointments

    Commenting on the new appointment, Keith Thompson, chief executive of CGT Catapult, said: “With over 20 years’experience in R&D, Jonathan has both commercialisation and drug development expertise. ... be a global leader in the development and

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    Their combined experience in corporate strategy, business development and commercialisation will be invaluable to the company’s continued growth as we advance our clinical programmes in blood cancers and rare genetic

  • Abeona Therapeutics names CEO Abeona Therapeutics names CEO

    Steven Rouhandeh, executive chairman of Abeona, said: “As CEO, Carsten Thiel brings a unique combination of extensive experience in research and global rare disease commercialisation to Abeona.

  • Zelluna Immunotherapy appoints chief technology officer Zelluna Immunotherapy appoints chief technology officer

    He will play a big part in the execution of Zelluna’s manufacturing strategy for clinical trials and commercialisation.”.

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Jim’s extensive experience in driving excellence across R&D, commercialisation, manufacturing, business development and capital formation will be invaluable as we continue to build a genomic medicine leader and develop

More from appointments
Approximately 0 fully matching, plus 118 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 32 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics